Trxc Stock Buy Or Sell -

: On August 22, 2024, KARL STORZ finalized its acquisition of Asensus Surgical.

: Shareholders at the time of the merger were entitled to receive the $0.35 per share cash payout. trxc stock buy or sell

AI responses may include mistakes. For financial advice, consult a professional. Learn more : On August 22, 2024, KARL STORZ finalized

: In March 2021, the company changed its name from TransEnterix to Asensus Surgical to align with its focus on "Performance-Guided Surgery". For financial advice, consult a professional

: Leading up to its acquisition, the company reported a Q2 2024 revenue of $2.2 million but sustained a net loss of $25.7 million for the same period. Investment Outlook

The ticker is no longer active for trading. TransEnterix, the company originally associated with that symbol, rebranded as Asensus Surgical and changed its ticker to ASXC in March 2021. Subsequently, Asensus Surgical was acquired by KARL STORZ and its stock was officially delisted in August 2024. Stock Status and Delisting